LEVEL OF SUPPORT FOR COMPREHENSIVE TOBACCO MEASURES AMONG THE MALE ADULTS AGED 15-49 YEARS IN ABUJA, NIGERIA May 15, 20220
PREVALENCE OF SALMONELLA TYPHI (S.TYPHI) CARRIER STATE AND ALTERED P53 GENE EXPRESSION IN CHRONIC CHOLECYSTITIS & CHOLELITHIASIS PATIENTS IN EASTERN INDIA May 15, 20220
CARDIOVASCULAR DISEASE RISK ASSESSMENT IN TYPE 2 DIABETES: ROLE OF MYELOPEROXIDASE AND APOLIPOPROTEIN B March 16, 20220
15May20220 LEVEL OF SUPPORT FOR COMPREHENSIVE TOBACCO MEASURES AMONG THE MALE ADULTS AGED 15-49 YEARS IN ABUJA, NIGERIA
15May20220 PREVALENCE OF SALMONELLA TYPHI (S.TYPHI) CARRIER STATE AND ALTERED P53 GENE EXPRESSION IN CHRONIC CHOLECYSTITIS & CHOLELITHIASIS PATIENTS IN EASTERN INDIA
16Mar20220 CARDIOVASCULAR DISEASE RISK ASSESSMENT IN TYPE 2 DIABETES: ROLE OF MYELOPEROXIDASE AND APOLIPOPROTEIN B
LEVEL OF SUPPORT FOR COMPREHENSIVE TOBACCO MEASURES AMONG THE MALE ADULTS AGED 15-49 YEARS IN ABUJA, NIGERIA May 15, 20220
PREVALENCE OF SALMONELLA TYPHI (S.TYPHI) CARRIER STATE AND ALTERED P53 GENE EXPRESSION IN CHRONIC CHOLECYSTITIS & CHOLELITHIASIS PATIENTS IN EASTERN INDIA May 15, 20220
CARDIOVASCULAR DISEASE RISK ASSESSMENT IN TYPE 2 DIABETES: ROLE OF MYELOPEROXIDASE AND APOLIPOPROTEIN B March 16, 20220
LEVEL OF SUPPORT FOR COMPREHENSIVE TOBACCO MEASURES AMONG THE MALE ADULTS AGED 15-49 YEARS IN ABUJA, NIGERIA15May20220 LEVEL OF SUPPORT FOR COMPREHENSIVE TOBACCO MEASURES AMONG THE MALE ADULTS AGED 15-49 YEARS IN ABUJA, NIGERIA Read More
KNOWLEDGE ABOUT SMOKING AND SECOND HAND SMOKE AMONG THE MALE ADULTS OF ABUJA, NIGERIA15May20220 KNOWLEDGE ABOUT SMOKING AND SECOND HAND SMOKE AMONG THE MALE ADULTS OF ABUJA, NIGERIA Read More
PREVALENCE OF SALMONELLA TYPHI (S.TYPHI) CARRIER STATE AND ALTERED P53 GENE EXPRESSION IN CHRONIC CHOLECYSTITIS & CHOLELITHIASIS PATIENTS IN EASTERN INDIA15May20220 PREVALENCE OF SALMONELLA TYPHI (S.TYPHI) CARRIER STATE AND ALTERED P53 GENE EXPRESSION IN CHRONIC CHOLECYSTITIS & CHOLELITHIASIS PATIENTS IN EASTERN INDIA Read More
CARDIOVASCULAR DISEASE RISK ASSESSMENT IN TYPE 2 DIABETES: ROLE OF MYELOPEROXIDASE AND APOLIPOPROTEIN B16Mar20220 CARDIOVASCULAR DISEASE RISK ASSESSMENT IN TYPE 2 DIABETES: ROLE OF MYELOPEROXIDASE AND APOLIPOPROTEIN B Read More
